Eliana Witchell RD - Evidence-Based Nutrition
Economics

Cost and Access to GLP-1 Medications

Plan the money before you plan the medication

Reviewed by Eliana Witchell, MSc, RD, CDELast reviewed: Version 1.0.0

Plan for approximately $400 CAD per month out-of-pocket (or $800–$1,500 USD without coverage in the US) before starting a GLP-1. Do not start unless you can commit to at least 12 months of continuous treatment. Do not use intermittently — the one-month-on, one-month-off approach wastes money and produces no durable benefit. If you cannot commit financially, save first and address non-medication approaches in the interim.

GLP-1 medications are expensive. In Canada, out-of-pocket cost for Wegovy or Zepbound is approximately $400 CAD per month without coverage; Saxenda and Rybelsus can be similar or lower. Manufacturer savings cards, alternate suppliers, and compounded versions (where legal and quality-controlled) can reduce cost. Practitioners universally advise against using a GLP-1 intermittently — the one-month-on-one-month-off approach produces no durable benefit and may create physiological unknowns. This page covers the honest financial picture, the one-year commitment rule, and the practical options when coverage is not available. Educational content. Cost and coverage change; verify current numbers with your pharmacist and insurer. Not individualized Medical Nutrition Therapy.

The one-year commitment rule

Practitioners consistently advise against starting a GLP-1 unless you can commit to at least 12 months of continuous treatment. The reasons are practical:

  • Habit-building during treatment requires time. Most of the habits that preserve results after discontinuation take at least 6–12 months to become automatic.
  • Intermittent use wastes money. One month of a GLP-1 produces minimal durable benefit.
  • Stop-start cycling is poorly studied physiologically. Unknown unknowns are not a small deal.
  • Rapid regain after short treatment typically returns weight as fat while any muscle loss persists — a worse metabolic state than the starting point.

If the budget does not support 12 months, save first. Address non-medication approaches in the interim. Come back to the GLP-1 conversation when the budget is ready.

Financial reality

Canadian reference

  • Wegovy ~ $400 CAD / month
  • Mounjaro / Zepbound similar
  • Saxenda typically lower
  • Rybelsus variable
  • Savings card discounts may apply

US reference

  • $800–$1,500 USD / month without coverage
  • Commercial insurance often covers partially
  • Manufacturer copay cards for commercial insurance
  • Medicare/Medicaid coverage variable

What to budget per year

  • Canada: $4,800+ CAD without coverage
  • US: $9,600–$18,000 USD without coverage
  • Plus ancillary: protein powder, supplements, training
  • Plus ancillary: prescriber visits, dietitian visits, labs

If the budget does not fit

  • Save first, treat later
  • Lower-cost options in the class (Saxenda often cheaper)
  • Compounded options where legal and quality-verified
  • Manufacturer assistance programs if eligible
  • Prioritize non-medication work while saving

When to seek individualized support

Cost planning plus treatment planning together produces better outcomes than either alone. If you live in Ontario, British Columbia, or Nova Scotia, individualized Medical Nutrition Therapy that can work alongside your financial and prescriber planning is available through Eliana's practice.

Common questions

What should I expect to pay out-of-pocket?
Canadian reference points (verify current pricing with your pharmacist): Wegovy approximately $400 CAD per month without coverage. Mounjaro/Zepbound similar. Saxenda typically lower. Rybelsus variable. US reference: $800–$1,500 USD per month without coverage for the branded weight-management medications. Manufacturer savings cards often reduce these substantially if you qualify.
What is the one-year commitment rule?
Practitioners consistently advise patients not to start a GLP-1 unless they can commit to at least 12 months of continuous use. The reasons are practical and physiological: building the habits that preserve results takes at least a year; intermittent use wastes money; coming off early typically produces rapid regain as fat; and the physiology of stop-start cycling is poorly studied. If you cannot commit to a year, a different treatment plan is usually the better call.
Why not just use it for a month or two?
One practitioner experience: a patient said she could not afford to keep going, so she would just use it for a month and stop. The advice was to stop her from starting. One month of a GLP-1 produces minimal durable benefit. The appetite suppression quiets food noise temporarily, but the habit and muscle foundations that carry long-term results do not have time to form. Money is effectively wasted.
What are manufacturer savings cards?
Manufacturer copay cards or savings programs offered by Novo Nordisk (Ozempic, Wegovy, Saxenda, Rybelsus) and Eli Lilly (Mounjaro, Zepbound). Eligibility rules vary — often restricted to commercially insured patients in the US. Ask your pharmacist and check the manufacturer websites for current programs. Can substantially reduce out-of-pocket cost when eligible.
What about compounded GLP-1 medications?
Compounded semaglutide and tirzepatide have been available through some specialty pharmacies during shortage periods of the branded products, often at lower cost. Legality and quality vary. In the US, recent regulatory actions have limited the availability of compounded versions once the branded shortage is resolved. Discuss with your prescriber and pharmacist rather than sourcing online.
What if I lose my coverage mid-treatment?
Call your prescriber before stopping abruptly. Options include: manufacturer assistance programs, a taper plan to preserve results rather than a cold stop, or a switch to a lower-cost option in the class. Sudden discontinuation is rarely the right move if it can be avoided.
Are there lower-cost medications in the class?
Saxenda (liraglutide, daily injection) is typically lower-cost than Wegovy or Zepbound in many jurisdictions. Some patients and prescribers choose Saxenda as a pragmatic starting point when cost is a primary constraint. Outcomes may be less impressive than the newer medications, but non-zero cost + non-zero efficacy can beat no treatment.
What about buying GLP-1 medications online?
Risky without a legitimate prescription and a verified licensed pharmacy. Quality, dosing accuracy, and safety are not guaranteed. Telehealth platforms that prescribe and ship through licensed pharmacies are a legitimate option in some jurisdictions; black-market or unverified online sources are not.
Can I budget for this with a spouse or partner who is also on a GLP-1?
Yes, and some families budget together. $400 CAD per person per month for two people is $9,600 per year. Not trivial. Plan financially the same way you would plan for any ongoing medical expense — as a line item, not a guess.

Related in this cluster

References

  1. Sehgal NKR, Tronieri JS, Ungar L, Guntuku SC. Self-reported side effects of semaglutide and tirzepatide in online communities. Nature Health. 2026. Published online April 10, 2026. (DOI)
  2. Practitioner case material: Eliana Witchell, MSc, RD, CDE. Clinical notes, 2023–2026. Anonymized.

Ready to go deeper?

If this page helped, the free Initial Consult Experience walks you through how Eliana approaches metabolic nutrition. Educational, self-directed, no credit card required.

Start Here First: Free Initial Consult ExperienceWhy This Is Different

Important Disclaimer: This program is for educational purposes only and does not replace individualized Medical Nutrition Therapy or medical care.

Personalized nutrition therapy services are available only in jurisdictions where Eliana Witchell, RD, CDE holds active licensure. Always consult with your healthcare provider before making changes to your diet, exercise, or medication regimen.

This page is for educational purposes only and does not replace individualized Medical Nutrition Therapy or medical care.